![]() ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. | ![]() ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders. | ||
Founding Date | Founding Date 2011 | Founding Date 2002 | Founding Date 2005 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Bainbridge Island, US HQ | Locations San Clemente, US HQ San Clemente, US | Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US |
Employees | Employees 31 | Employees 4348% decrease | Employees 5144% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3 m | Valuation ($) 71.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $11.3m (FY, 2020) | Revenue (est.) $32m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $5m (FY, 2020) | Cost of goods $4.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $6.3m (FY, 2020) | Gross profit $27.8m (FY, 2025) |
Net income | Net income N/A | Net income ($21.6m) (FY, 2020) | Net income ($14m) (FY, 2025) |

ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
View company
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
View company